Human papilloma virus inhibition by anti-sense oligonucleotides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 21, 2001
Issued Date -
N/A
app pub date -
Apr 28, 2000
filing date -
Sep 5, 1997
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Antisense oligonucleotides having phosphorothioate backbone structure and sequences complementary to nucleotides contained with residues 415 to 445 of human papilloma virus 16 (HPV-16) are disclosed. Methods of treatment using antisense oligonucleotides having phosphorothioate backbone structure and nucleotide sequences complementary to nucleotides contained with residues 415 to 445 of HPV-16 are disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully